5 completed. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 2 | Completed 2 |
Follow Keratoconjunctivitis: new trials by email Literature Review of Keratoconjunctivitis trials Research Report on Keratoconjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease INV-102, Vehicle - Dry Eye Disease | Phase 1 / Phase 2 | Completed | Invirsa, Inc. | 84 | 2022-08-30 | 2026-09-18 |
| A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers PP-001, Placebo - Keratoconjunctivitis, Ocular Surface Disease | Phase 1 | Completed | Panoptes Pharma GmbH | 45 | 2018-11-20 | 2024-01-12 |
| Safety and Efficacy of PG101 for Dry Eye Syndrome PG101 - Dry Eye Syndrome | Phase 1 / Phase 2 | Completed | Rhodes Pharmaceuticals, L.P. | 72 | 2013-12-01 | 2014-03-05 |
| A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease R348 Ophthalmic Solution, 0.2%, R348 Ophthalmic Solution, 0.5%, R348 Ophthalmic Solution, 1.0% - Keratoconjunctivitis Sicca | Phase 1 | Completed | Rigel Pharmaceuticals | 36 | 2012-11-01 | 2014-08-04 |
| A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS) voclosporin ophthalmic solution - Keratoconjunctivitis Sicca | Phase 1 | Completed | Lux Biosciences, Inc. | 35 | 2009-02-01 | 2012-06-22 |
Keratoconjunctivitis Sicca (4) · Dry Eye Syndromes (2)
Conjunctival Diseases (5) · Conjunctivitis (5) · Corneal Diseases (5) · Eye Diseases (5) · Keratitis (5) · Lacrimal Apparatus Diseases (4) · Dry Eye Syndromes (2)
Gels (1)
Invirsa, Inc. (1) · Lux Biosciences, Inc. (1) · Panoptes Pharma GmbH (1) · Rhodes Pharmaceuticals, L.P. (1) · Rigel Pharmaceuticals (1)
United States (4) · Austria (1)
Gail Torkildsen, M.D. (1) · Gail Torkildsen, MD (1) · Robert Shalwitz, MD (1)